Bo Hong

2.2k total citations
80 papers, 1.6k citations indexed

About

Bo Hong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Bo Hong has authored 80 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 31 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Bo Hong's work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (9 papers) and RNA modifications and cancer (8 papers). Bo Hong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (9 papers) and RNA modifications and cancer (8 papers). Bo Hong collaborates with scholars based in China, United States and Hong Kong. Bo Hong's co-authors include Wafik S. El‐Deiry, Shengliang Zhang, Varun V. Prabhu, A. Pieter J. van den Heuvel, Vivian Wai Yan Lui, David T. Dicker, Anthony T.�C. Chan, Joshua E. Allen, Levy Kopelovich and Edwin P. Hui and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Bo Hong

76 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Hong China 24 790 564 358 196 160 80 1.6k
Neveen Said United States 24 803 1.0× 491 0.9× 397 1.1× 343 1.8× 132 0.8× 36 1.8k
Nina Kramer Austria 16 874 1.1× 855 1.5× 384 1.1× 204 1.0× 170 1.1× 24 2.2k
Kee-Ho Lee South Korea 20 1.2k 1.6× 597 1.1× 296 0.8× 199 1.0× 119 0.7× 35 2.2k
Yubin Mao China 18 1.1k 1.5× 687 1.2× 502 1.4× 220 1.1× 111 0.7× 23 2.0k
Jong Kuk Park South Korea 25 1.2k 1.5× 552 1.0× 365 1.0× 135 0.7× 150 0.9× 53 1.8k
Yihui Shi United States 21 841 1.1× 493 0.9× 386 1.1× 276 1.4× 138 0.9× 50 1.8k
Naoyo Nishida Japan 12 837 1.1× 401 0.7× 366 1.0× 150 0.8× 140 0.9× 27 1.5k
Hongsheng Wang China 21 845 1.1× 575 1.0× 337 0.9× 195 1.0× 204 1.3× 49 1.6k
Xiaochun Peng China 23 807 1.0× 490 0.9× 226 0.6× 321 1.6× 181 1.1× 74 1.8k

Countries citing papers authored by Bo Hong

Since Specialization
Citations

This map shows the geographic impact of Bo Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hong more than expected).

Fields of papers citing papers by Bo Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hong. The network helps show where Bo Hong may publish in the future.

Co-authorship network of co-authors of Bo Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hong. A scholar is included among the top collaborators of Bo Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hong. Bo Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yufei, et al.. (2025). Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review. Clinica Chimica Acta. 569. 120176–120176. 2 indexed citations
2.
Wang, Jialiang, Xiaopeng Zhang, Jian Qi, et al.. (2025). Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with EGFR or KRAS Mutation. Cancer Control. 32. 2925725411–2925725411. 1 indexed citations
3.
Qi, Jian, Bo Hong, Shujie Wang, et al.. (2024). Plasma cell‐free DNA methylome‐based liquid biopsy for accurate gastric cancer detection. Cancer Science. 115(10). 3426–3438. 8 indexed citations
4.
Wang, Jialiang, Xiang Huang, Yanfei Zhou, et al.. (2024). CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer. BMC Medical Imaging. 24(1). 45–45. 8 indexed citations
5.
Jin, Bo, Jiong Wang, Wei Zuo, et al.. (2023). Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy. International Immunopharmacology. 120. 110280–110280. 4 indexed citations
6.
Zhang, Yani, et al.. (2023). The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer. BMC Medical Genomics. 16(1). 103–103. 3 indexed citations
7.
Zhang, Jinping, Kecheng Chen, Chuanbo Ding, et al.. (2022). Fabrication of chitosan/PVP/dihydroquercetin nanocomposite film for in vitro and in vivo evaluation of wound healing. International Journal of Biological Macromolecules. 206. 591–604. 69 indexed citations
8.
Zhao, Shujie, et al.. (2020). Extraction, characterization and antioxidant activity evaluation of polysaccharides from Smilacina japonica. International Journal of Biological Macromolecules. 151. 576–583. 38 indexed citations
9.
Liu, Xiaoli, Wei Wang, Hong Li, et al.. (2019). A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer. Investigational New Drugs. 37(6). 1166–1176. 15 indexed citations
10.
Sheng, Yi, Wei Wang, Bo Hong, et al.. (2018). Upregulation of KIF20A correlates with poor prognosis in gastric cancer. Cancer Management and Research. Volume 10. 6205–6216. 37 indexed citations
11.
Qian, Yun, Limin Feng, Tian-Hao Weng, et al.. (2017). MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown. Cellular Physiology and Biochemistry. 44(2). 494–504. 18 indexed citations
12.
Prabhu, Varun V., Bo Hong, Joshua E. Allen, et al.. (2016). Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation. Cancer Research. 76(7). 1989–1999. 49 indexed citations
13.
Hong, Bo. (2016). Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology. 22(18). 4538–4538. 12 indexed citations
14.
Zhang, Shengliang, Lanlan Zhou, Bo Hong, et al.. (2015). Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. Cancer Research. 75(18). 3842–3852. 92 indexed citations
15.
Hong, Bo, Varun V. Prabhu, Shengliang Zhang, et al.. (2013). Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53. Cancer Research. 74(4). 1153–1165. 69 indexed citations
16.
Wang, Wenge, Jean‐Nicolas Gallant, Sharyn I. Katz, et al.. (2011). Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biology & Therapy. 12(3). 229–238. 44 indexed citations
17.
Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Kevin Ki‐Wai Ho, et al.. (2010). Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death. Oncogene. 30(9). 1127–1134. 48 indexed citations
18.
19.
Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Yeung Ho, et al.. (2009). STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro. International Journal of Cancer. 125(8). 1884–1893. 61 indexed citations
20.
Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Yuen‐Keng Ng, et al.. (2009). Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis. 30(12). 2085–2094. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neveen Said Breakdown of academic impact, for papers by Nina Kramer Breakdown of academic impact, for papers by Kee-Ho Lee Breakdown of academic impact, for papers by Yubin Mao Breakdown of academic impact, for papers by Jong Kuk Park Breakdown of academic impact, for papers by Yihui Shi Breakdown of academic impact, for papers by Naoyo Nishida Breakdown of academic impact, for papers by Hongsheng Wang Breakdown of academic impact, for papers by Xiaochun Peng
Rankless by CCL
2026